ONCOTYPE DX USES A TISSUE SAMPLE FROM A BREAST CANCER TUMOR, TYPICALLY FROM A CORE BIOPSY OR SURGERY, TO AN…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT940825FE016
- Contractor
- EXACT SCIENCES CORPORATION
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $69,498
- Period of performance
- Sep 26, 2025 – Oct 27, 2025
- NAICS
- 621511 — Medical Laboratories
- Place of performance
- EGLIN AFB, FL, 325421283, USA
- Competition
- FULL AND OPEN COMPETITION · 1 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $69,498 · Obligated $69,498 · Potential value $69,498 · Latest action obligation $69,498
- Parent award
- V797D70053
Public award description
ONCOTYPE DX USES A TISSUE SAMPLE FROM A BREAST CANCER TUMOR, TYPICALLY FROM A CORE BIOPSY OR SURGERY, TO ANALYZE THE ACTIVITY OF A SPECIFIC SET OF GENES WITHIN THE CANCER CELLS.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Agency: Department of Defense
- PSC Q301 — Product Service Code Q301
- Federal market intelligence software